US4670551A
(en)
*
|
1984-06-21 |
1987-06-02 |
Ciba-Geigy Corporation |
Epoxy steroids
|
DE69129193T2
(de)
*
|
1991-01-29 |
1998-07-30 |
Shionogi Seiyaku K K Trading U |
Triterpenderivat
|
US6150347A
(en)
*
|
1992-04-21 |
2000-11-21 |
The Curators Of The University Of Missouri |
Use of aldosterone antagonists to inhibit myocardial fibrosis
|
US6245755B1
(en)
|
1992-04-21 |
2001-06-12 |
Curators Of The Unversity Of Missouri |
Use of aldosterone antagonists to inhibit myocardial fibrosis
|
JPH05329410A
(ja)
*
|
1992-05-29 |
1993-12-14 |
Sekisui Plastics Co Ltd |
マスキング材
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
US6268392B1
(en)
|
1994-09-13 |
2001-07-31 |
G. D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothiepines and HMG Co-A reductase inhibitors
|
US6262277B1
(en)
*
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
WO1996040255A2
(fr)
*
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Procede de traitement de la fibrose cardiaque par une combinaison therapeutique d'un antagoniste de l'angiotensine ii et d'un antagoniste de l'aldosterone epoxy-steroide
|
CA2224079A1
(fr)
*
|
1995-06-07 |
1996-12-19 |
G.D. Searle & Co. |
Therapie mixte a base d'un antagoniste epoxy-steroidien de l'aldosterone et d'un antagoniste de l'angiotensine ii pour le traitement de l'insuffisance cardiaque globale
|
US20020045746A1
(en)
*
|
1995-12-11 |
2002-04-18 |
Barton Kathleen P. |
Eplerenone crystalline form
|
EA009176B1
(ru)
*
|
1995-12-11 |
2007-12-28 |
Дж.Д.Серл Энд Ко. |
Способ получения 7-альфа-карбоксил-9,11-эпоксистероидов и промежуточных продуктов, используемых для их получения, и общий способ эпоксидирования по олефиновым двойным связям
|
EP1167380A3
(fr)
*
|
1995-12-11 |
2004-12-08 |
G.D. Searle & Co. |
Composés 11.alpha.-Hydroxy-steroid-4,6-dien-3-ones et un procédé de leur préparation
|
US20050159594A1
(en)
*
|
1995-12-11 |
2005-07-21 |
Pharmacia Corporation |
Eplerenone crystal form exhibiting enhanced dissolution rate
|
US20020038021A1
(en)
*
|
1995-12-11 |
2002-03-28 |
Barton Kathleen P. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
AU747959B2
(en)
*
|
1995-12-11 |
2002-05-30 |
G.D. Searle & Co. |
Processes and intermediates for the preparation of 9, 11-epoxy steroids
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US6887991B1
(en)
|
1996-12-11 |
2005-05-03 |
G. D. Searle & Company |
Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein
|
RO120710B1
(ro)
*
|
1996-12-11 |
2006-06-30 |
G.D.Searle & Co. |
Procedeu pentru obţinerea 3-ceto-7alfa-alcoxicarbonil-delta4,5-steroizilor şi intermediari pentru obţinerea acestora
|
EP1223174A3
(fr)
*
|
1996-12-11 |
2005-03-16 |
G.D. Searle & Co. |
Procédés de production de 3-cetone-7alpha-alkoxycarbonyl-delta4,5 Stéroides et intermédiaires appropriés à cet effet
|
CA2298453A1
(fr)
*
|
1998-05-29 |
1999-12-09 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede de production d'assaisonnements liquides ayant la saveur de legumes marines dans une pate de son de riz salee
|
IL142911A0
(en)
*
|
1998-11-06 |
2002-04-21 |
Searle & Co |
Combination therapy of angiotensin converting enzyme inhibitor and aldosterone antagonist for reducing morbidity and mortality from cardiovascular disease
|
UA74141C2
(uk)
|
1998-12-09 |
2005-11-15 |
Дж.Д. Сірл Енд Ко. |
Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
|
AU779264B2
(en)
*
|
1998-12-23 |
2005-01-13 |
G.D. Searle Llc |
Combinations for cardiovascular indications
|
WO2000038722A1
(fr)
|
1998-12-23 |
2000-07-06 |
G.D. Searle & Co. |
COMBINAISONS D'INHIBITEURS DE LA PROTEINE DE TRANSFERT DE L'ESTER DE CHOLESTERYLE ET D'INHIBITEURS DE LA HMG CoA-REDUCTASE UTILISEES DANS LE CADRE DE TROUBLES CARDIO-VASCULAIRES
|
CA2356158C
(fr)
*
|
1998-12-23 |
2008-09-02 |
G.D. Searle Llc |
Combinaisons d'inhibiteurs de la proteine de transfert du cholesteryle-ester et de derives de l'acide nicotinique utilisees dans le cadre de troubles cardio-vasculaires
|
AU2157500A
(en)
|
1998-12-23 |
2000-07-31 |
G.D. Searle Llc |
Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
|
IL143946A0
(en)
|
1998-12-23 |
2002-04-21 |
Searle Llc |
Combinations of ileal bile acid transport inhibitors and cholesteryl ester transfer protein for cardiovascular indications
|
PT1140190E
(pt)
*
|
1998-12-23 |
2003-02-28 |
Searle Llc |
Combinacoes de inibidores do transporte ileal dos acidos biliares e agentes sequestrantes dos acidos biliares usadas para problemas cardiovasculares
|
EA004231B1
(ru)
*
|
1998-12-23 |
2004-02-26 |
Джи.Ди.Сирл Ллс |
Сочетание ингибиторов белка, переносящего эфир холестерила, и производных фибриновой кислоты для сердечно-сосудистых показаний
|
EA200100707A1
(ru)
|
1998-12-23 |
2001-12-24 |
Джи.Ди.Сирл Ллс |
Сочетания ингибиторов транспорта желчных кислот в подвздошной кишке и производных фибриновой кислоты для сердечно-сосудистых показаний
|
US20030096798A1
(en)
*
|
1999-11-09 |
2003-05-22 |
Williams Gordon H. |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
US20030203884A1
(en)
*
|
1999-11-09 |
2003-10-30 |
Pharmacia Corporation |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
EP1505072A3
(fr)
*
|
1999-12-08 |
2006-06-21 |
Pharmacia Corporation |
Forme cristalline d'eplerenone possédant une vitesse de dissolution accrue
|
HUP0203032A3
(en)
*
|
1999-12-08 |
2003-04-28 |
Pharmacia Corp Chicago |
Eplerenone crystalline form exhibiting enhanced dissolution rate, process for their preparation and pharmaceutical compositions containing them and their use
|
ES2240209T3
(es)
*
|
1999-12-08 |
2005-10-16 |
Pharmacia Corporation |
Composiciones de eplerenona nanoparticulada.
|
JP4219105B2
(ja)
*
|
1999-12-08 |
2009-02-04 |
ファルマシア コーポレーション |
エプレレノン結晶形
|
EP1527782A1
(fr)
*
|
1999-12-08 |
2005-05-04 |
Pharmacia Corporation |
Compositions nanoparticulaires d'eplérenone
|
EP1286984A2
(fr)
|
2000-03-10 |
2003-03-05 |
Pharmacia Corporation |
Procede de preparation de tetrahydrobenzothiepines
|
AU2001247331A1
(en)
*
|
2000-03-10 |
2001-09-24 |
Pharmacia Corporation |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
AU2001261434A1
(en)
*
|
2000-05-11 |
2001-11-26 |
Pharmacia Corporation |
Aldosterone antagonist composition for release during aldosterone acrophase
|
AU1604001A
(en)
*
|
2000-06-13 |
2001-12-24 |
Pharmacia Corp |
Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
|
AU2001279050B2
(en)
*
|
2000-07-27 |
2006-10-19 |
Pharmacia Corporation |
Epoxy-steroidal aldosterone antagonist and beta-adrenergic antagonist combination therapy for treatment of congestive heart failure
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
ES2251505T3
(es)
*
|
2000-08-28 |
2006-05-01 |
Pharmacia Corporation |
Uso de un antagonista del receptor de aldosterona para mejorar la funcion cognoscitiva.
|
CN1531590A
(zh)
*
|
2000-10-30 |
2004-09-22 |
|
赭曲霉11α-羟化酶和氧化还原酶
|
MXPA03004112A
(es)
*
|
2000-11-09 |
2003-08-19 |
Astrazeneca Ab |
Composicion farmaceutica oral que contiene un copolimero de bloque.
|
US8168616B1
(en)
|
2000-11-17 |
2012-05-01 |
Novartis Ag |
Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
|
US20040077625A1
(en)
*
|
2001-07-25 |
2004-04-22 |
Tremont Samuel J. |
Novel 1,4-benzothiazepine and 1,5-benzothiazepine compounds as inhibitors of apical sodium codependent bile acid transport abd taurocholate uptake
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US6740663B2
(en)
*
|
2001-11-02 |
2004-05-25 |
G.D. Searle, Llc |
Mono- and di-fluorinated benzothiepine compounds as inhibitors of apical sodium co-dependent bile acid transport (ASBT) and taurocholate uptake
|
CA2469616A1
(fr)
|
2001-12-12 |
2003-06-19 |
James W. Aiken |
Methode de traitement de troubles ophtalmiques a l'aide d'antagonistes epoxy-steroidiens des recepteurs de l'aldosterone
|
EP1465885A4
(fr)
|
2002-01-17 |
2005-04-27 |
Pharmacia Corp |
Nouveaux composes d'alkyl/aryl hydroxy ou cetothiepine servant d'inhibiteurs du transport des acides biliaires de type ileal et de l'absorption de taurocholate
|
PL373029A1
(en)
*
|
2002-03-18 |
2005-08-08 |
Pharmacia Corporation |
Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
|
MXPA04009033A
(es)
*
|
2002-03-18 |
2005-01-25 |
Pharmacia Corp |
Combinacion de un antagonista de receptor de aldosterona y acido nicotinico o un derivado de acido nicotinico.
|
EP1487540A2
(fr)
*
|
2002-03-20 |
2004-12-22 |
Pharmacia Corporation |
Formulation de l'eplerenone stable au stockage
|
US7235655B2
(en)
*
|
2002-03-22 |
2007-06-26 |
Pharmacia & Upjohn Company |
Processes to prepare eplerenone
|
DE60322852D1
(de)
*
|
2002-03-22 |
2008-09-25 |
Pharmacia & Upjohn Co Llc |
Verfahren zur herstellung von eplerenon
|
AU2003285485A1
(en)
*
|
2002-08-16 |
2004-03-03 |
Pharmacia & Upjohn Company Llc |
5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
|
US20070066579A1
(en)
*
|
2002-08-16 |
2007-03-22 |
White Michael J |
5-androsten-3beta-ol steroid intermediates and processs for their preparation
|
TW200407150A
(en)
*
|
2002-11-06 |
2004-05-16 |
Upjohn Co |
Processes for preparing 7- carboxy substituted steroids
|
CA2500580A1
(fr)
*
|
2002-11-07 |
2004-05-27 |
Pharmacia & Upjohn Company Llc |
Procedes de preparation de 5-androstenes substitues en c-7
|
CL2004000544A1
(es)
*
|
2003-03-18 |
2005-01-28 |
Pharmacia Corp Sa Organizada B |
Uso de una combinacion farmaceutica, de un antagonista del receptor de aldosterona y un inhibidor de endopeptidasa neutral, util para el tratamiento y prevencion de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopati
|
CL2004000545A1
(es)
*
|
2003-03-18 |
2005-01-28 |
Pharmacia Corp Sa Organizada B |
Uso de un antagonista de los receptores de aldosterona y un antagonista de receptores de endotelina para el tratamiento o profilaxis de una condicion patologica relacionada con hipertension, disfuncion renal, insulinopatia y enfermedades cardiovascul
|
CL2004000574A1
(es)
*
|
2003-03-21 |
2005-02-11 |
Pharmacia Corp Sa Organizada B |
Proceso para preparar un compuesto 17-espirolactona o la sal de lactona abierta por carbonilacion del correspondiente 17-alquenil o alquinil derivado, los intermediarios que se usan y su proceso de obtencion.
|
WO2004100871A2
(fr)
*
|
2003-05-09 |
2004-11-25 |
Pharmacia Corporation |
Combinaison d'un antagoniste du recepteur de l'aldosterone et d'un inhibiteur de renine
|
US20040265948A1
(en)
*
|
2003-06-27 |
2004-12-30 |
White Michael Jon |
Microbial method for hydrolysis and oxidation of androst-5-ene and pregn-5-ene steroid esters
|
GB0327839D0
(en)
|
2003-12-01 |
2003-12-31 |
Novartis Ag |
Organic compounds
|
TW200602352A
(en)
*
|
2004-03-22 |
2006-01-16 |
Upjohn Co |
Improved process for the preparation of 9,11 epoxy steroids
|
US20070196471A1
(en)
*
|
2004-04-02 |
2007-08-23 |
Thosar Shilpa S |
Micronized Eplerenone Compositions
|
US20050232957A1
(en)
*
|
2004-04-14 |
2005-10-20 |
Katz Kenneth A |
Compositions and methods for moisturizing skin
|
CN1321128C
(zh)
*
|
2005-07-15 |
2007-06-13 |
浙江医药股份有限公司新昌制药厂 |
孕甾-4-烯-7,21-二甲酸,9,11-环氧-17-羟基-3-氧代,γ-内酯,甲酯,(7α,11α,17α)-的制备方法
|
WO2007025780A2
(fr)
*
|
2005-09-02 |
2007-03-08 |
Recordati Ireland Limited |
Antagonistes des recepteurs de l'aldosterone
|
EP1842543A1
(fr)
|
2006-04-05 |
2007-10-10 |
Speedel Pharma AG |
Composition pharmaceutique comprennant un inhibiteur de l'aldosteron synthase et un antagoniste de recepteur mineralcorticoide
|
US20070248665A1
(en)
*
|
2006-04-24 |
2007-10-25 |
Sherman Bernard C |
Compositions comprising co-precipitate of eplerenone and a water-soluble excipient
|
DE102006028032A1
(de)
*
|
2006-06-14 |
2007-12-20 |
Henkel Kgaa |
Aufhell- und/oder Färbemittel mit Nitrilen
|
US20100086586A1
(en)
*
|
2006-12-21 |
2010-04-08 |
Brett Antony Mooney |
Pharmaceutical Composition
|
CA2582496A1
(fr)
*
|
2007-03-20 |
2008-09-20 |
Apotex Pharmachem Inc. |
Procede ameliore permettant la preparation et la purification de l'eplerenone
|
FR2917975B1
(fr)
|
2007-06-26 |
2009-10-16 |
Ceva Sante Animale Sa |
Compositions et traitement de l'insuffisance cardiaque chez les animaux mammiferes non humains
|
DE102008026793A1
(de)
*
|
2008-06-02 |
2009-12-03 |
Bayer Schering Pharma Aktiengesellschaft |
C-Ring-substituierte Pregn-4-en-21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
|
CN101863951B
(zh)
*
|
2009-04-15 |
2012-06-06 |
浙江省天台县奥锐特药业有限公司 |
依普利酮的制备方法
|
MX2011012628A
(es)
|
2009-05-28 |
2011-12-14 |
Novartis Ag |
Derivados amino-propionicos sustituidos como inhibidores de neprilisina.
|
AR076706A1
(es)
|
2009-05-28 |
2011-06-29 |
Novartis Ag |
Derivados aminobutiricos sustituidos como inhibidores de neprilisina
|
JO2967B1
(en)
|
2009-11-20 |
2016-03-15 |
نوفارتس ايه جي |
Acetic acid derivatives of carbamoyl methyl amino are substituted as new NEP inhibitors
|
CN102811730B
(zh)
*
|
2010-02-08 |
2014-07-09 |
杜涛 |
孕激素作为糖皮质激素增敏剂的使用
|
EP2977084B1
(fr)
|
2010-05-10 |
2017-07-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Procedes et compositions pour le traitement de l'accumulation de fluides dans et/ou sous la retine
|
JP6180930B2
(ja)
|
2010-06-16 |
2017-08-16 |
アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル |
創傷治癒過程における再上皮化を刺激するための方法及び組成物
|
TR201007653A2
(tr)
|
2010-09-20 |
2012-04-24 |
Bi̇lgi̇ç Mahmut |
Eplerenon içeren farmasötik kompozisyon
|
US8877815B2
(en)
|
2010-11-16 |
2014-11-04 |
Novartis Ag |
Substituted carbamoylcycloalkyl acetic acid derivatives as NEP
|
US8673974B2
(en)
|
2010-11-16 |
2014-03-18 |
Novartis Ag |
Substituted amino bisphenyl pentanoic acid derivatives as NEP inhibitors
|
WO2012107513A1
(fr)
*
|
2011-02-10 |
2012-08-16 |
Crystal Pharma, S.A.U. |
Procédé d'obtention de la drospirénone
|
ITMI20121037A1
(it)
*
|
2012-06-14 |
2013-12-15 |
Ind Chimica Srl |
Processo per la preparazione di nitrili utili come intermedi per la sintesi di molecole ad attivita' farmacologica
|
KR20150119109A
(ko)
|
2013-02-14 |
2015-10-23 |
노파르티스 아게 |
Nep (중성 엔도펩티다제) 억제제로서의 치환된 비스페닐 부타노익 포스폰산 유도체
|
CN104262450A
(zh)
*
|
2014-09-19 |
2015-01-07 |
江苏嘉逸医药有限公司 |
依普利酮的制备及精制方法
|
ES2699923T3
(es)
|
2014-10-17 |
2019-02-13 |
Ind Chimica Srl |
Proceso para la preparación de 7alfa-(metoxicarbonil)-3-oxo-17alfa-pregn-4,9(11)-dien-21,17-carbolactona, un intermedio útil para la síntesis de moléculas con actividad farmacológica
|
WO2017055248A1
(fr)
|
2015-09-28 |
2017-04-06 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthodes et compositions pharmaceutiques pour le traitement d'une insuffisance cardiaque
|
EP3362095B1
(fr)
|
2015-10-13 |
2020-11-25 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthodes et préparations pharmaceutiques pour le traitement de la neovascularisation choroidienne
|
CN105753930A
(zh)
*
|
2016-03-30 |
2016-07-13 |
北京万全德众医药生物技术有限公司 |
依普利酮的一种合成方法
|
EP3490606B8
(fr)
|
2016-07-26 |
2024-04-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antagoniste des récepteurs des minéralocorticoïdes pour le traitement de l'arthrose
|
JOP20190086A1
(ar)
|
2016-10-21 |
2019-04-18 |
Novartis Ag |
مشتقات نافثيريدينون جديدة واستخدامها في معالجة عدم انتظام ضربات القلب
|
UY38072A
(es)
|
2018-02-07 |
2019-10-01 |
Novartis Ag |
Compuestos derivados de éster butanoico sustituido con bisfenilo como inhibidores de nep, composiciones y combinaciones de los mismos
|
WO2023031277A1
(fr)
|
2021-08-31 |
2023-03-09 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Méthodes de traitement de la rosacée oculaire
|